Covenant Partners, LLC Takeda Pharmaceutical CO LTD Transaction History

Covenant Partners, LLC

$337 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$13.89 - $15.04 $393,642 - $426,233	28,340 New	28,340 $393,000
Q3 2023 Oct 20, 2023	SELL	$15.03 - $16.32 $5,531 - $6,005	-368 Reduced 0.91%	40,015 $619,000
Q2 2023 Aug 11, 2023	SELL	$15.57 - $17.11 $52,268 - $57,438	-3,357 Reduced 7.67%	40,383 $634,000
Q1 2023 Apr 19, 2023	SELL	$15.28 - $16.48 $36,091 - $38,925	-2,362 Reduced 5.12%	43,740 $720,000
Q4 2022 Feb 17, 2023	BUY	$12.42 - $15.62 $29,336 - $36,894	2,362 Added 5.4%	46,102 $719,000
Q3 2022 Nov 10, 2022	SELL	$12.8 - $28.65 $60,441 - $135,285	-4,722 Reduced 9.74%	43,740 $567,000
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $63,935 - $72,482	4,722 Added 10.8%	48,462 $694,000
Q4 2021 Feb 15, 2022	SELL	$13.17 - $16.4 $19,662 - $24,485	-1,493 Reduced 3.3%	43,740 $596,000
Q3 2021 Nov 12, 2021	BUY	$16.3 - $17.26 $319,023 - $337,812	19,572 Added 76.27%	45,233 $741,000
Q2 2021 Aug 02, 2021	SELL	$16.55 - $18.64 $473,942 - $533,793	-28,637 Reduced 52.74%	25,661 $432,000
Q1 2021 May 11, 2021	SELL	$16.71 - $19.9 $123,403 - $146,961	-7,385 Reduced 11.97%	54,298 $991,000
Q4 2020 Feb 10, 2021	BUY	$15.39 - $18.97 $202,486 - $249,588	13,157 Added 27.11%	61,683 $1.12 Million
Q3 2020 Nov 10, 2020	SELL	$17.1 - $19.19 $83,328 - $93,512	-4,873 Reduced 9.13%	48,526 $866,000
Q2 2020 Aug 17, 2020	SELL	$14.59 - $19.5 $217,259 - $290,374	-14,891 Reduced 21.81%	53,399 $957,000
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $38,500 - $60,056	-2,957 Reduced 4.15%	68,290 $1.04 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $66,844 - $82,486	-3,960 Reduced 5.27%	71,247 $1.41 Million
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $189,342 - $210,914	11,724 Added 18.47%	75,207 $1.29 Million
Q2 2019 Aug 15, 2019	BUY	$16.58 - $20.49 $74,278 - $91,795	4,480 Added 7.59%	63,483 $1.12 Million
Q1 2019 May 16, 2019	BUY	$16.7 - $21.52 $91,716 - $118,187	5,492 Added 10.26%	59,003 $1.2 Million
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $836,912 - $1.13 Million	53,511 New	53,511 $900,000

Others Institutions Holding TAK

# of Institutions

320

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$182 Million
0.04% of portfolio
Mondrian Investment Partners LTD London, X0

7.74M
Shares

$107 Million
1.74% of portfolio
Morgan Stanley New York, NY

4.99M
Shares

$69.1 Million
0.01% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.35M
Shares

$60.2 Million
0.03% of portfolio
Goldman Sachs Group Inc New York, NY

3.72M
Shares

$51.5 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Partners, LLC with notifications on news.

Account